0
0

Cart (0)

Home > NDSRI's > Rivaroxaban

Rivaroxaban - NDSRI's
Wishlist
Select options

Rivaroxaban EP Impurity D

  • CAT NUMBER DCTI-C-3273
  • CAS NUMBER 1365267-35-1
  • MOLECULAR FORMULA C29H32N6O9
  • MOLECULAR WEIGHT 608.61
Select options
Wishlist
References
FAQ's

References

  1. Thomas, Christian R., Method for producing 5-chloro-N-(({5S)-2-oxo-3- 4-(3-oxo-4-morpholinyl)-phenyl] -1,3-oxazolidin-5-yl-methyl)-2-thiophene carboxamide, Bayer Healthcare A.-G., Germany, EP1583761B1, February 23, 2011
  2. Rohde, G., Determination of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Volume: 872, Issue: 1-2, Pages: 43-50, 2008

Frequently Asked Questions

Comparative research and rigorous quality control ensure that generic versions are equivalent in purity, safety, and efficacy.

During quality control testing, Rivaroxaban impurities use analytical techniques such as HPLC methods to identify and quantify the impurities present in Rivaroxaban.

Due to different synthetic procedures, the level of Rivaroxaban impurities might vary.

Rivaroxaban impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart
jQuery(window).on('load', function() { $('input[name="productname"]').val($('.product_title').html()); });